To hear about similar clinical trials, please enter your email below
Trial Title:
Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital
NCT ID:
NCT05970471
Condition:
Preference, Patient
Pharmacist-Patient Relations
Caregiver
Cancer
Conditions: Official terms:
Mouth Neoplasms
Conditions: Keywords:
Preference, Patient
Pharmacist-Patient Relations
Cancer of Colon
Cancer, Breast
Lung Cancer
Prostate Cancer
Renal Cancer
caregiver
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs)
have been established in France. Their goal is to provide the patient with the means to
identify, prevent and limit adverse effects and to know who to refer to in case of a
serious adverse effect, perform a pharmaceutical analysis of the prescription, and
participate in the improvement and evaluation of overall compliance. OPCs are conditioned
by the needs, expectations, and involvement of the patients in their care. In healthcare,
patients are increasingly encouraged to play an active role in the knowledge and
management of their health, express their concerns and preferences, and participate in
medical decisions. Thus, it is essential to elicit their preferences. The discrete-choice
experiment (DCE) is the validated and recommended method of the International Society for
Pharmacoeconomics and Outcomes Research for such a task.
Detailed description:
To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs)
have been established in France. Their goal is to provide the patient with the means to
identify, prevent and limit adverse effects and to know who to refer to in case of a
serious adverse effect, perform a pharmaceutical analysis of the prescription, and
participate in the improvement and evaluation of overall compliance. OPCs are conditioned
by the needs, expectations, and involvement of the patients in their care. In healthcare,
patients are increasingly encouraged to play an active role in the knowledge and
management of their health, express their concerns and preferences, and participate in
medical decisions. Thus, it is essential to elicit their preferences. The discrete-choice
experiment (DCE) is the validated and recommended method of the International Society for
Pharmacoeconomics and Outcomes Research for such a task.
Criteria for eligibility:
Study pop:
240 patients - 60 Caregivers - 360 healhcare professionnals (pharmacist, oncologists,
general practitioners)
Sampling method:
Non-Probability Sample
Criteria:
of patients:
Main inclusion Criteria:
- Patients with lung, prostate breast, prostate or renal cancer;
- Patients with oral cancer drugs;
- Patients accepted to take par in pharmaceutical consultation in hospital.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
CHU de Besançon
Address:
City:
Besançon
Zip:
25030
Country:
France
Status:
Recruiting
Contact:
Last name:
Virginie NERICH, PhD
Email:
v1nerich@chu-besancon.fr
Investigator:
Last name:
Virginie NERICH, phD
Email:
Principal Investigator
Start date:
August 10, 2023
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Centre Hospitalier Universitaire de Besancon
Agency class:
Other
Source:
Centre Hospitalier Universitaire de Besancon
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05970471
